FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893890930> ?p ?o ?g. }

• W2893890930 abstract "Many naturally occurring peptides have poor proteolytic stability, which limits their therapeutic applications. Cyclotides are plant-derived cyclic peptides that resist proteolysis due to their highly constrained structure, comprising a head-to-tail cyclic backbone and three disulfide bonds that form a cystine-knotted core. This structure makes them useful as scaffolds onto which peptide sequences (epitopes) can be grafted. In this study, VHH7, an alpaca-derived nanobody that targets murine class II MHC molecules, was used for the targeted delivery of cyclotides to antigen-presenting cells (APCs). The cyclotides MCoTI-I, and MCoTI-I with a HA-tag (YPYDVPDYA) grafted into loop 6 (MCoTI-HA), were tested for immunogenic properties. To produce the requisite VHH7-peptide conjugates, a site-specific sortase A-catalyzed reaction in combination with a copper-free strain-promoted cycloaddition reaction was used. MCoTI-I alone did not display any obvious antibody response, thus showing the capacity of cyclotides as immunologically silent scaffolds. By contrast, MCoTI-I conjugated to VHH7 elicited antibodies against cyclic or linear MCoTI-I, thus suggesting a simple and robust approach for targeting cyclotides to APCs, and potentially to other cell types. A similar antibody response was observed when MCoTI-HA was conjugated to VHH7, but there was no reactivity toward a linear HA-tag itself, suggesting differences in conformational constraint between cyclotide-presented and linear epitopes. Studies of commercially available HA antibodies applied to MCoTI-HA confirmed that the conformation of peptide immunogens affects their reactivity. Thus, the production of antibodies that recognize constrained epitopes may benefit from engraftment onto scaffolds such as cyclotides. More broadly, this study validates that a prototypic cyclotide, a member of a peptide family that has proven to be useful as drug design scaffolds in many other studies, can efficiently reach a specific target in vivo." @default.
• W2893890930 created "2018-10-05" @default.
• W2893890930 creator A5009745693 @default.
• W2893890930 creator A5011180189 @default.
• W2893890930 creator A5032599270 @default.
• W2893890930 creator A5058339404 @default.
• W2893890930 creator A5079106979 @default.
• W2893890930 creator A5079308758 @default.
• W2893890930 creator A5081514135 @default.
• W2893890930 creator A5087029469 @default.
• W2893890930 creator A5088481026 @default.
• W2893890930 date "2018-09-24" @default.
• W2893890930 modified "2023-10-16" @default.
• W2893890930 title "Targeted Delivery of Cyclotides via Conjugation to a Nanobody" @default.
• W2893890930 cites W1527663665 @default.
• W2893890930 cites W1578336471 @default.
• W2893890930 cites W1859997696 @default.
• W2893890930 cites W1956322610 @default.
• W2893890930 cites W1965338154 @default.
• W2893890930 cites W1966916002 @default.
• W2893890930 cites W1966934571 @default.
• W2893890930 cites W1967823483 @default.
• W2893890930 cites W1973131208 @default.
• W2893890930 cites W1973993174 @default.
• W2893890930 cites W1974629753 @default.
• W2893890930 cites W1976595458 @default.
• W2893890930 cites W1983318869 @default.
• W2893890930 cites W1984111577 @default.
• W2893890930 cites W1984687223 @default.
• W2893890930 cites W199186236 @default.
• W2893890930 cites W1993695450 @default.
• W2893890930 cites W1994656998 @default.
• W2893890930 cites W1995017064 @default.
• W2893890930 cites W1995390287 @default.
• W2893890930 cites W1997099073 @default.
• W2893890930 cites W1997730366 @default.
• W2893890930 cites W2006458848 @default.
• W2893890930 cites W2010972861 @default.
• W2893890930 cites W2011697808 @default.
• W2893890930 cites W2018426009 @default.
• W2893890930 cites W2024669426 @default.
• W2893890930 cites W2028277934 @default.
• W2893890930 cites W2034663072 @default.
• W2893890930 cites W2041619855 @default.
• W2893890930 cites W2046410511 @default.
• W2893890930 cites W2048833964 @default.
• W2893890930 cites W2054392131 @default.
• W2893890930 cites W2056405796 @default.
• W2893890930 cites W2061441787 @default.
• W2893890930 cites W2073660388 @default.
• W2893890930 cites W2075601360 @default.
• W2893890930 cites W2083368932 @default.
• W2893890930 cites W2089409411 @default.
• W2893890930 cites W2089788910 @default.
• W2893890930 cites W2111346723 @default.
• W2893890930 cites W2131063559 @default.
• W2893890930 cites W2136544846 @default.
• W2893890930 cites W2142623863 @default.
• W2893890930 cites W2154714625 @default.
• W2893890930 cites W2154721421 @default.
• W2893890930 cites W2158699257 @default.
• W2893890930 cites W2167785149 @default.
• W2893890930 cites W2169707043 @default.
• W2893890930 cites W2170338669 @default.
• W2893890930 cites W2176716563 @default.
• W2893890930 cites W2233887337 @default.
• W2893890930 cites W2417431203 @default.
• W2893890930 cites W2557128364 @default.
• W2893890930 cites W2619645085 @default.
• W2893890930 doi "https://doi.org/10.1021/acschembio.8b00653" @default.
• W2893890930 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30248263" @default.
• W2893890930 hasPublicationYear "2018" @default.
• W2893890930 type Work @default.
• W2893890930 sameAs 2893890930 @default.
• W2893890930 citedByCount "13" @default.
• W2893890930 countsByYear W28938909302019 @default.
• W2893890930 countsByYear W28938909302020 @default.
• W2893890930 countsByYear W28938909302021 @default.
• W2893890930 countsByYear W28938909302022 @default.
• W2893890930 countsByYear W28938909302023 @default.
• W2893890930 crossrefType "journal-article" @default.
• W2893890930 hasAuthorship W2893890930A5009745693 @default.
• W2893890930 hasAuthorship W2893890930A5011180189 @default.
• W2893890930 hasAuthorship W2893890930A5032599270 @default.
• W2893890930 hasAuthorship W2893890930A5058339404 @default.
• W2893890930 hasAuthorship W2893890930A5079106979 @default.
• W2893890930 hasAuthorship W2893890930A5079308758 @default.
• W2893890930 hasAuthorship W2893890930A5081514135 @default.
• W2893890930 hasAuthorship W2893890930A5087029469 @default.
• W2893890930 hasAuthorship W2893890930A5088481026 @default.
• W2893890930 hasBestOaLocation W28938909302 @default.
• W2893890930 hasConcept C104317684 @default.
• W2893890930 hasConcept C147483822 @default.
• W2893890930 hasConcept C159654299 @default.
• W2893890930 hasConcept C165175003 @default.
• W2893890930 hasConcept C181199279 @default.
• W2893890930 hasConcept C185592680 @default.
• W2893890930 hasConcept C195616568 @default.
• W2893890930 hasConcept C203014093 @default.
• W2893890930 hasConcept C21951064 @default.

• next